Quest PharmaTech Closes $1,000,000 Private Placement
EDMONTON, ALBERTA – Quest PharmaTech Inc. (TSX-V: QPT) ), a pharmaceutical company developing and commercializing products for the treatment of cancer announces that it has closed a $1,000,000 unit offering private placement.
“I am pleased that Quest was able to close this financing to provide much needed funding for the Company’s clinical programs. These proceeds will also assist the Company to make arrangements for long term financing through the Company’s wholly-owned subsidiary, OncoQuest Inc.” said Mr. Pierre Vermette, CFO of Quest.